The effects of anticonvulsant drugs on NMDA-EPSP, AMPA-EPSP, and GABA- IPSP in the rat hippocampus

Brain Research Bulletin

Volumn 42, Issue 4, 1997, Pages 297-302

  Yi Ping Lee Ko, Gladys ^a   Brown Croyts, Laurie M ^a   Teyler, Timothy J ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

AMPA; GABA; NMDA; Phenobarbital; Phenytoin; Valproic acid

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTICONVULSIVE AGENT; ION CHANNEL; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; GABAERGIC TRANSMISSION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTICONVULSANTS; ELECTROPHYSIOLOGY; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; N-METHYLASPARTATE; PHENOBARBITAL; PHENYTOIN; RATS; RATS, INBRED STRAINS; VALPROIC ACID;

EID: 0031037683     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(96)00268-7     Document Type: Article

References (26)

1. Abramowicz M. Drugs for epilepsy. Abramowicz M. The medical letter on drugs and therapeutics. 37:1995;37-40 The Medical Letter, Inc, New Rochelle, NY.
2. Bertram E. H., Lothman E. W. NMDA receptor antagonists and limbic status epilepticus: A comparison with standard anticonvulsant. Epilepsy Res. 5:1990;177-184.
3. 3H]norepinephrine efflux. Eur. J. Pharmacol. 254:1994;307-309.
4. Fuller T. A., Olney J. W. Only certain anticonvusants protect against kainate neurotoxicity. Neurobehav. Toxicol. Teratol. 3:1981;355-361.
5. Gean P.-W., Hung C.-C., Hung C.-R., Tsai J.-J. Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices. Brain Res. Bull. 33:1994;333-336.
6. Grover L. M., Teyler T. J. Two components of LTP induced by different patterns of afferent activation. Nature. 347:1990;477-479.
7. Jordan S. J., Jefferys J. G. R. Sustained and selective block of IPSPs in brain slices from rats made epileptic by intrahippocampal tetanus toxin. Epilepsy Res. 11:1992;119-129.
8. Kobrinsky E. M., Pearson H. A., Dolphin A. C. Low- and high-voltage-activated calcium channel currents and their modulation in the dorsal root ganglion cell line ND7-23. Neuroscience. 58:1994;539-552.
9. Lambert N. A., Borroni A. M., Grover L. M., Teyler T. J. Hyperpolarizing and depolarizing GABAa receptor-mediated dendritic inhibition in area CA1 of the rat hippocampus. J. Neurophysiol. 66:1991;1538-1548.
10. Lee G. Y.-P., Brown L. M., Teyler T. J. The effects of anticonvulsant drugs on long-term potentiation (LTP) in the rat hippocampus. Brain Res. Bull. 39:1996;39-42.
11. Leung L. S., Shen B. Long-term potentiation in hippocampal CA1: Effects of afterdischarges, NMDA antagonists, and anticonvulsant. Exp. Neurol. 119:1993;205-214.
12. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 18:1993;485-502.
13. Löscher W. Anticonvulsant drug mechaniss. Klee M. R., Mareš P., Speckmann E.-J., Lux H. D., Rokyta R. Physiology, pharmacology and development of epileptogenic phenomena: Experimental brain research series 20. 1991;193-200 Springer Verlag, Berlin.
14. Löscher W. Valproate induced changes in GABA metabolism at the subcellular level. Biochem. Pharmacol. 30:1981;1364-1366.
15. Macdonald R. L., Kelly K. M. Mechanisms of action of currently prescribed and newly developed antiepileptic drugs. Epilepsia. 35:((Suppl. 4)):1994;S41-S50.
16. McNamara J. O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
17. McNamara J. O. The neurobiological basis of epilepsy. Trends Neurosci. 15:1992;357-359.
18. Sethy V. H., Sage G. P. Modulation of release of acetylcholine from the striatum by a proposed excitatory amino acid antagonist U-54494A: Comparison with known antagonists, diazepam and phenytoin. Neuropharmacology. 31:1992;111-114.
19. Short K. R., Tabakoff B. Chronic barbiturate treatment increases NMDA receptors but decreases kinate receptors in mouse cortex. Eur. J. Pharmacol. 230:1993;111-114.
20. Silva-Barrat C., Champagnat J., Brailowsky S., Menini C., Naquet R. In vivo and in vitro studies of the epileptic focus induced by the interruption of a cortical GABA infusion. Klee M. R., Mareš P., Speckmann E.-J., Lux H. D., Rokyta R. Physiology, pharmacology and development of epileptogenic phenomena: Experimental brain research series 20. 1991;107-110 Springer Verlag, Berlin.
21. Talwar D. Mechanisms of antiepileptic drug action. Pediatr. Neurol. 6:1990;289-295.
22. Taverna F. A., Cameron B., Hampson D. L., Wang L., MacDonald J. F. Sensitivity of AMPA receptors to pentobarbital. Eur. J. Pharmacol. 267:1994;R3-R5.
23. Urbánska E., Dziki M., Kleinrok Z., Czuczwar S. J., Turski W. A. Influence of MK-801 on the anticonvulsant activity of antiepileptics. Eur. J. Pharmacol. 200:1991;277-282.
24. Williamson R., Wheal H. V. The contribution of AMPA and NMDA receptors to graded bursting activity in the hippocampal CA1 region in an acute in vitro model of epilepsy. Epilepsy Res. 12:1992;179-188.
25. Yaari Y., Jensen M. S., Konnerth A. Mechanisms underlying enhanced synaptic activation of NMDA receptors during hippocampal seizures. Klee M. R., Marěs P., Speckmann E.-J., Lux H. D., Rokyta R. Physiology, pharmacology and development of epileptogenic phenomena: Experimental brain research series 20. 1991;71-74 Springer Verlag, Berlin.
26. Zeise M. L., Kasparow S., Zieglgänsberger M. Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro. Brain Res. 544:1991;345-348.